Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1757)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (14)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4175)
  2. Weinberg Fellows (2758)
  3. Hematologic Malignancies, Division of (2493)
  4. Solid Tumor Oncology Division (2424)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (346)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4494)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
    Journal Article

    Wang, S.; Mondal, S.; Zhao, C.; Berishaj, M.; Ghanakota, P.; Batlevi, C. L.; Dogan, A.; Seshan, V. E.; Abel, R.; Green, M. R.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
    Review

    Ball, B.; Stein, E. M.
    Haematologica (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Emerging epigenetic-modulating therapies in lymphoma
    Review

    Sermer, D.; Pasqualucci, L.; Wendel, H. G.; Melnick, A.; Younes, A.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Stage IV lung carcinoids: Spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
    Journal Article

    Rekhtman, N.; Desmeules, P.; Litvak, A. M.; Pietanza, M. C.; Santos-Zabala, M. L.; Ni, A.; Montecalvo, J.; Chang, J. C.; Beras, A.; Preeshagul, I. R.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • MET IHC is a poor screen for MET amplification or MET exon 14 mutations in lung adenocarcinomas: Data from a tri-institutional cohort of the Lung Cancer Mutation Consortium
    Journal Article

    Guo, R.; Berry, L. D.; Aisner, D. L.; Sheren, J.; Boyle, T.; Bunn, P. A. Jr; Johnson, B. E.; Kwiatkowski, D. J.; Drilon, A.; Sholl, L. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • One plus one does not always equal two, especially with regard to hypomethylating agents: The question of synergy of azacitidine and lenalidomide for treatment of relapsed acute myeloid leukemia and myelodysplastic syndromes post allogeneic hematopoietic stem cell transplant
    Editorial

    Bewersdorf, J. P.; Stahl, M.; Zeidan, A. M.
    Expert Review of Hematology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
    Journal Article

    Sherman, E. J.; Dunn, L. A.; Schòˆder, H.; Ho, A. L.; Baxi, S. S.; Ghossein, R. A.; Haque, S. S.; Sima, C.; Tuttle, R. M.; Pfister, D. G.
    Cancer (2019)

    Fulltext@MSK | Save
  • Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Bhatt, V.; Hilden, P.; Smith, M.; Thoren, K.; Cho, C.; Shah, G. L.; Maloy, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save